CCAR1 and neoplasm: In addition, IHC analysis confirmed that DCLK1 inhibitor decreased the protein expression of DCLK1 and CCAR1 in subcutaneous tumour in both of DCLK1‐overexpressing and the control groups (Figure 8G).